18 June, 2022 Central Drugs Standard Control Organization (CDSCO), the central drug regulatory agency of Government of India has published the list of all the vaccines approved in India for the prophylaxis of Covid-19. The data consists of all…


17 June, 2022 Central Drugs Standard Control Organization (CDSCO), the central drug regulatory agency of Government of India has issued a new gazette notification and waives off the requirement of Transmissible Spongiform Encephalopathies (TSEs) or Bovine Spongiform Encephalopathy (BSE) Certification…

Indian drug regulatory system is governed by the provisions laid down under Drugs and Cosmetics Act, 1940 and Rules, 1945 made thereunder. With changing times many new rules viz. Medical Device Rules, 2017, New Drugs and Clinical Trial Rules,…

April 30, 2022 Central Drugs Standard Control Organization (CDSCO) under the aegis of Ministry of Health and Family Welfare, Government of India has been taking many steps to control the menace of unapproved and irrational Fixed Dose Combinations (FDCs).…

April 26, 2022 Central Drugs Standard Control Organization (CDSCO), the Drug Regulatory Agency of Government of India granted restricted emergency use authorization (EUA) to Bharat Biotech's Covaxin as a COVID-19 vaccine to vaccinate children between the age of 6-12…
Recent Post
- CDSCO Introduces Online Process for Additional Variant Applications in Cosmetics
- India Imposes National Ban on Nimesulide for Veterinary Use Due to Toxicity Risks
- Major Relief for MSME Pharma Manufacturers: MoHFW Extends Deadline for Revised GMP Compliance
- Pharmacovigilance system compliance in India
- Simplifying Clinical Trial Amendment Approvals in India